Stay updated on Upadacitinib vs Abatacept in RA Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib vs Abatacept in RA Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    - The record removing the online-ahead-of-print note and updating the date to reflect August 28, 2025 is replaced with a complete citation including the Online ahead of print status. Overall, the core article information is preserved, with a shift in publication metadata rather than content.
    Difference
    0.2%
    Check dated 2025-10-12T15:08:48.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:32:18.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Added a trial citation and a v3.1.0 update; removed a Drug Safety section, erratum context, and older revision tag. Core content shifts toward a specific study citation while trimming safety-topic categories.
    Difference
    0.5%
    Check dated 2025-09-28T03:25:48.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    - Version updated to v3.0.2; the 'Back to Top' element was removed. No changes to core content, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-13T17:37:58.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page has been updated to include a new research article on the safety profile of Upadacitinib, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    1%
    Check dated 2025-09-06T15:04:54.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as new MedlinePlus related topics on arthritis and drug safety. Additionally, there are updates to the safety profiles and studies related to upadacitinib.
    Difference
    22%
    Check dated 2025-08-30T11:48:44.000Z thumbnail image

Stay in the know with updates to Upadacitinib vs Abatacept in RA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.